As of 2025-12-23, the Relative Valuation of Selecta Biosciences Inc (SELB) is (0.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -191.6%.
The range of the Relative Valuation is (1.20) - 0.80 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 14.7x | 10.0x |
| Forward P/E multiples | 21.4x - 31.5x | 26.4x |
| Fair Price | (1.20) - 0.80 | (0.81) |
| Upside | -236.4% - -9.5% | -191.6% |
| Date | P/E |